Literature DB >> 4626630

On the mechanism of platelet aggregation induced by heparin, protamine and polybrene.

C Eika.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4626630     DOI: 10.1111/j.1600-0609.1972.tb00937.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


× No keyword cloud information.
  18 in total

1.  The effect of heparin on platelet aggregation by common inductors and by ristocetin in congenital bleeding disorders due to factor VIII or fibrinogen defects.

Authors:  A Girolami; L De Marco; L Virgolini; R Peruffo; F Fabris
Journal:  Blut       Date:  1975-10

2.  Low molecular weight protamine as nontoxic heparin/low molecular weight heparin antidote (III): preliminary in vivo evaluation of efficacy and toxicity using a canine model.

Authors:  L M Lee; L C Chang; S Wrobleski; T W Wakefield; V C Yang
Journal:  AAPS PharmSci       Date:  2001

3.  Inhibition of prostaglandin E1-responsive platelet adenylate cyclase by heparin: a study of the mechanism of inhibition and its relevance to platelet aggregation.

Authors:  H Amirrasooli; S Mac Neil; S Tomlinson
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

4.  Effects of heparin on platelet aggregation and release and thromboxane A2 production.

Authors:  S F Mohammad; W H Anderson; J B Smith; H Y Chuang; R G Mason
Journal:  Am J Pathol       Date:  1981-08       Impact factor: 4.307

5.  Thrombocytopenia accompanying a reaction to protamine sulfate.

Authors:  J C Horrow
Journal:  Can Anaesth Soc J       Date:  1985-01

6.  Nadroparine-induced skin necrosis on a patient with essential thrombocythaemia: a case report.

Authors:  Manousos-Georgios Pramateftakis; Dimitrios Kanellos; Stefanos Psomas; Ioannis Kanellos
Journal:  Cases J       Date:  2009-03-10

7.  Clinical benefit of low molecular weight heparin for ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitor.

Authors:  Jung Sun Cho; Sung-Ho Her; Ju Yeal Baek; Mahn-Won Park; Hyoung Doo Kim; Myung Ho Jeong; Young keun Ahn; Shung Chull Chae; Seung Ho Hur; Taek Jong Hong; Young Jo Kim; In Whan Seong; Jei Keon Chae; Jay Young Rhew; In Ho Chae; Myeong Chan Cho; Jang Ho Bae; Seung Woon Rha; Chong Jim Kim; Donghoon Choi; Yang Soo Jang; Junghan Yoon; Wook Sung Chung; Jeong Gwan Cho; Ki Bae Seung; Seung Jung Park
Journal:  J Korean Med Sci       Date:  2010-10-26       Impact factor: 2.153

8.  Platelet activation following intravenous injection of a conventional heparin: absence of effect with a low molecular weight heparinoid (Org 10172).

Authors:  D P Mikhailidis; V A Fonseca; M A Barradas; J Y Jeremy; P Dandona
Journal:  Br J Clin Pharmacol       Date:  1987-10       Impact factor: 4.335

Review 9.  Serotonin and acute cardiovascular disorders.

Authors:  R S Reneman; P J van der Starre
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

10.  Porcine heparin increases postoperative bleeding in cardiopulmonary bypass patients.

Authors:  L I Iverson; F G Duhaylongsod; J N Young; R R Ecker; C L Ennix; R L Moretti; M Farrar; R Hayes; J Lee; I A May
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.